Gabelli Funds’s Verona Pharma VRNA Stock Holding History

Gabelli Funds’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-372,744	Closed	-$39.8M	–	1301
2025 Q3	$39.8M	Buy	+372,744	New	+$38.9M	0.27%	88

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Gabelli Funds's VRNA Position: Q4 2025 in Review

Gabelli Funds sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 372,744 shares — an estimated $39.8M sold.

Gabelli Funds first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $39.8M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Gabelli Funds reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Gabelli Funds sold 372,744 Verona Pharma shares in Q4 2025, an estimated $39.8M.
Gabelli Funds first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Gabelli Funds's Verona Pharma position peaked at $39.8M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Gabelli Funds's 13F filing for Q4 2025, filed 5 Feb 2026.